JODI KIRSCHBAUM, MD
Endocrinology, Diabetes & Metabolism Physician in VALLEY STREAM, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
JODI KIRSCHBAUM, MD filed 3,939 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in VALLEY STREAM, New York, prescribing 55% generic.
- 4K
- Part D claims, 2023
- 55%
- generic prescribing
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
JODI KIRSCHBAUM, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
3,939 Top 9% higher than 91% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
JODI KIRSCHBAUM, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about JODI KIRSCHBAUM, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in New York
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among New York providers
Endocrinology, Diabetes & Metabolism Physician share within New York
Endocrinology, Diabetes & Metabolism Physician is one of the more visible NUCC categories in New York
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Endocrinology, Diabetes & Metabolism Physician US NPIs
Specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
JODI KIRSCHBAUM, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 260 W SUNRISE HWY, VALLEY STREAM, NY, 11581, with a listed phone of (516) 825-3600. NPI 1104854405 was issued on 06/28/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KIRSCHBAUM most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 3,939 prescription claims written by this provider, covering 491 Medicare beneficiaries and totaling roughly $2.2 million in drug spend, split 45% brand-name and 55% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1104854405 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 06/28/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm JODI KIRSCHBAUM, MD's current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
License & disciplinary context — New York NYSBPMC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to JODI KIRSCHBAUM, MD. To verify JODI KIRSCHBAUM, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
45% brand-name claims vs 55% generic, on 3,939 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 10,033
- Total Day Supply
- 299,158
- Brand vs Generic
- 45% brand / 55% generic
- Brand Drug Cost
- $2.1M
- Generic Drug Cost
- $72K
Patient Demographics
- Average Patient Age
- 72.9 years
- Avg HCC Risk Score
- 1.70
- Gender Split
- 65% female / 35% male
- Age Distribution
- <65: 54, 65-74: 235, 75-84: 167, 85+: 35
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What JODI KIRSCHBAUM, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Glimepiride
Glimepiride
284 claims
- Atorvastatin Calcium
Atorvastatin Calcium
255 claims
- Ozempic
Ozempic
235 claims
- Levothyroxine Sodium
Levothyroxine Sodium
204 claims
- Jardiance
Jardiance
201 claims
- Metformin Hcl Er
Metformin Hcl Er
195 claims
- Novolog Flexpen
Novolog Flexpen
169 claims
- Januvia
Januvia
158 claims
| Drug | Claims |
|---|---|
| Glimepiride | 284 |
| Atorvastatin Calcium | 255 |
| Ozempic Semaglutide | 235 |
| Levothyroxine Sodium | 204 |
| Jardiance Empagliflozin | 201 |
| Metformin Hcl Er Metformin Hcl | 195 |
| Novolog Flexpen Insulin Aspart | 169 |
| Januvia Sitagliptin Phosphate | 158 |
| Losartan Potassium | 157 |
| Metformin Hcl | 138 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Endocrinology, Diabetes & Metabolism Physician Overview
How JODI KIRSCHBAUM, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
JODI KIRSCHBAUM, MD's 3,939 claims are above the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as KIRSCHBAUM.
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New York
Frequently Asked Questions
What is JODI KIRSCHBAUM, MD's specialty? ▼
How much does JODI KIRSCHBAUM, MD prescribe under Medicare Part D? ▼
Where is JODI KIRSCHBAUM, MD located? ▼
What is JODI KIRSCHBAUM, MD's NPI number? ▼
Does JODI KIRSCHBAUM, MD prescribe more brand-name or generic drugs? ▼
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
What drugs does JODI KIRSCHBAUM, MD prescribe most often? ▼
Does JODI KIRSCHBAUM, MD accept Medicare? ▼
How can I verify JODI KIRSCHBAUM, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology